The world of cannabis is a source of confusion and endless questions. Over the years, the cannabis plant has provided hundreds of entirely natural compounds. Based on their biologically active properties, these molecules fall into two main categories: terpenes and cannabinoids. The cannabinoid category brings together a diverse range of compounds, the most common of which are tetrahydrocannabinol (THC) and cannabidiol (CBD). THC and CBD tend to cause confusion among cannabis enthusiasts. However, there is an important difference between the two. The chemical structures and actions of these cannabinoids vary considerably.
Our article will help you learn more about the differences between CBD and THC.
Differences between CBD and THC
The difference between CBD and THC is generally understood in terms of THC’s psychoactive effects, which CBD does not have. But beyond this generalisation, it is worth noting that CBD and THC differ in how they interact with the body’s endocannabinoid system (ECS) receptors.
The differences between these two main cannabis molecules can also be seen in their respective properties.
Differences in how they interact with the nervous system
CBD and THC have similar molecular structures. Their chemical composition shows that each has 21 carbon atoms, 30 hydrogen atoms and 2 oxygen atoms. However, these atoms are arranged differently. The difference lies in the position of a single hydrogen atom. This is precisely what accounts for the difference between CBD and THC.
It is worth remembering that the ECS relies in part on CB1 and CB2 receptors. CB1 receptors are found in areas of the brain responsible for mental and physical processing. CB2 receptors, meanwhile, are found in the central nervous system and the immune system. THC is characterised by its interaction with CB1 receptors. This explains why it causes the high experienced by cannabis users.
Like THC, CBD also acts on the endocannabinoid system. However, it interacts with the system differently. CBD interacts with CB2 receptors and only inhibits them to a limited extent. It does, however, increase levels of endocannabinoids such as anandamide, a molecule often referred to as the “molecule of happiness”.
The way each CBD or THC molecule interacts with the body therefore determines its properties.
Properties of CBD
CBD is thought to have several properties that may surprise many people.
Potential anxiolytic and anti-inflammatory properties of CBD
Anxiety and pain have a considerable impact on patients’ quality of life. This condition affects the body’s immune system, triggering an immediate response known as inflammation.
Studies have shown that chronic inflammatory reactions can contribute to the development of tumours and even cancer-related pain, as well as severe pain associated with conditions such as back pain, rheumatism, arthritis, multiple sclerosis or cancer. Needless to say, the structure of the organs concerned is affected.
A study carried out in 2007 by researchers at the California Pacific Medical Center showed promising results for the use of CBD. It may have a powerful anti-inflammatory effect. CBD may also help combat stress and anxiety while providing a sense of wellbeing and relaxation. What is more, unlike opioids or painkillers, its effects are thought to be long-lasting and not to cause dependence.
Potential analgesic properties
Several research teams have also studied the potential analgesic properties of CBD. These include teams at scientific research laboratories in Israel, Spain and the United States studying pain. Their findings highlight the potential analgesic properties of CBD. Other studies have also explored CBD’s analgesic properties.
Other potential properties
CBD is also thought to have several other properties: antioxidant, anti-addictive and anti-angiogenic properties.
Properties of THC
CBD and THC have an entourage effect. However, it is important to recognise that THC has certain properties of its own. Despite its psychoactive properties, THC may relieve certain ailments or symptoms in patients, such as neuropathic pain, the side effects of chemotherapy, intraocular pressure associated with glaucoma, loss of appetite, asthma, sleep apnoea or Parkinson’s disease.
The entourage effect: the link between CBD and THC
The effects of CBD and THC are not always at odds. They are even often referred to as sister molecules. The science of cannabinoids reveals a well-known concept: the entourage effect. The cannabis plant contains hundreds of chemical molecules known as cannabinoids, and the entourage effect is based on the idea that these cannabinoids are more powerful in combination. The term entourage effect is used when CBD produces much more pronounced effects when combined with other cannabinoids (such as THC) or other organic compounds (terpenes, flavonoids).
This entourage effect has been the subject of several studies whose findings have yet to be disproved. According to these studies, consuming whole-plant extracts produces not only different effects, but also more effects than consuming some pure compounds in isolation.
In addition, a study published by Professor Jeremy R. Johnson in the Journal of Pain and Symptom Management in 2010 put forward a related view. Taking THC or CBD alone is not guaranteed to be fully effective when it comes to relieving certain types of pain, he stated. The professor noted that they were also less convincing than a placebo alone. However, using CBD and THC in combination can greatly improve a patient’s condition.
What is more, another study published in the same journal in 2011 also showed that, in natural settings, various cannabinoids combined with terpenes and other flavonoids can benefit from synergies, and when administered as isolates. As the authors state, certain conditions cannot be treated with a single cannabinoid.
A number of publications have emerged along these lines. They report that THC alone is thought to have significant therapeutic benefits, such as analgesic properties. Other publications have also shown that combining CBD with other compounds found in cannabis could greatly reduce THC’s toxicity.
This entourage effect has also been highlighted by Russo in relation to certain conditions (depression, anxiety, insomnia, dementia and addiction), which, according to his research, require a combination of terpenes and other cannabinoids such as CBD and THC for treatment. Focusing on two terpenes (limonene and linalool), he showed that CBD and THC could be more effective in treating these conditions when combined with terpenes. In addition, for conditions such as dementia in patients with Alzheimer’s disease, Russo also states that THC is only effective when combined with three terpenes: limonene, linalool and pinene. The same results were found for terpenes such as linalool, caryophyllene and myrcene in sleep disorders.
Finally, the entourage effect has also been demonstrated in animals. A 2019 study published in Frontiers in Pharmacology investigated the effects of CBD and THC in a zebrafish model of neural hyperactivity and concluded that these cannabinoids act synergistically.
CBD and THC: what does the law say?
The distinction between CBD and THC is also reflected in the legal status of each cannabinoid.
International organisations’ positions and foreign legislation
A number of international institutions have indeed come out in favour of CBD. By removing it from the list of narcotic drugs, they have legalised its use. France is one such example.
The WHO’s position
The WHO, or World Health Organization, removed CBD from the list of stimulant products in 2017. It recommends further research to uncover its potential therapeutic benefits.
What the UN and the International Anti-Doping Agency say
As for the UN, it is worth noting that the drug conventions make no reference to CBD. The same is true of the International Anti-Doping Agency, which has not included CBD on its list of banned substances since 1 January 2018.
What the CJEU, or Court of Justice of the European Union, says
29 November 2020 is an important date for future legislation on CBD and THC, not least in the context of French law. In the Kanavape case, EU lawmakers clarified that, since CBD oil does not cause side effects such as dependence or psychoactive effects, a decision to prohibit its use or consumption would violate EU law.
In its ruling, the judge considered it important to establish a legal threshold above which consuming or using CBD would be illegal.